News

Researchers from The University of Texas MD Anderson Cancer Center will present promising results from clinical trials in ...
A study published earlier this month confirms what many of us already know: Colorectal cancer rates are rising dramatically among young people. In fact, colorectal cancer is the leading cause of ...
A new implant safely triggers potent immune responses against hard-to-treat cancers showing "promise" for pancreatic and ...
DelveInsight’s, “Metastatic Colorectal Cancer Pipeline Insight 2025” report provides comprehensive insights about 150+ ...
They explained how an immunoprotective device near the tumor microenvironment containing cells engineered ... and distal ...
CytomX Therapeutics, Inc.’s CTMX share price has surged by 6.39%, which has investors questioning if this is right time to ...